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Modulation of class-II antigen expression in 
human thyroid epithelial cell cultures 
B. E. Wenzel 1 , H . A r n h o l d t 2 , S. Grammerstorf 1 , 
R. Gutekunst 1 and P. C. Scriba 1 
Department of Internal Medicine1, Institute of Pathology2, Medical University, Lübeck, FRG 
Abstract. The modulation of HLA-D expression of 
thyroid epithelial cells (TEC) was studied in vitro by 
means of immunofluorescence. Under serum-free cul-
ture conditions, TSH and TSH-receptor antibodies 
induce HLA-D on TECs derived from GD-patients. 
Serum-free culture conditions provide a higher avail-
ability of TSH-receptors by a 'right side right' polarity 
of the cellular morphology. There was no evidence for 
IFN-y producing cell contaminations on GD-TECs. 
T S H in contrast to IFN-y does not induce HLA-DQ on 
TECs . HLA-DQ is not displayed by spontaneously class-
I I antigen expressing GD-TECs. Methimazole as well as 
Perchlorate do not suppress HLA-D expression of 
TECs . 
Classically, only immuno-competent cells, namely 
macrophages or dendrit ic cells are able to present 
antigen together with the immuno-regulatory 
class-II self-antigen (Balfour et al. 1981). These 
class-II antigens ( in man H L A - D locii) can also be 
f o u n d in vivo (Hanafusa et al. 1983) and be 
induced o n thyro id epithelial cells (TEC) by vari-
ous agents in v i t ro . I n this study we were inter-
ested in which potential in vivo regulators o f 
t h y r o i d cell functions could modulate H L A - D 
expression. We investigated the possibility that 
there might exist a mechanism to induce H L A - D 
expression dif ferent than the well documented 
pathway via IFN-y (Todd et al. 1985; Davies et al. 
1985; Weetman et al. 1985). Namely, the chronic 
s t imulat ion o f the TSH-receptor and/or the ad-
minis trat ion o f iodine, methimazole, perchlorate, 
interferon-y, TSH-receptor antibodies i n TECs 
g r o w n in culture medium with or without serum 
supplementation was studied. This aimed at the 
role that polarity o f three dimensional structures 
play i n antigen-presentation in v i t ro as suggested 
i n vivo (Londei et al. 1984; Wenzel et al. 1986). 
Materials and Methods 
Patients 
Thyroid tissue was obtained from patients with Graves' 
disease (GD) or non-toxic goitre (NTG). GD-patients 
were iodine loaded for 10 days before surgery. They 
also had thyroid stimulating antibodies (TSAb), and 
6/7 had microsomal (M-antibodies). Patients with NTG 
were all void of thyroid antibodies. 
Thyroid epithelial cells (TECs) 
Thyroid tissue was minced, washed intensively with 
calcium- and magnesium-free phosphate buffer saline 
(PBS) and digested enzymatically two times for 1 h at 
37°C with 4 mg/ml collagenase. Cells were then washed 
twice in PBS containing 10% foetal calf serum (FCS), 
separated from erythrocytes and auto-rosettes by den-
sity centrifugation, washed again and plated on 8 cham-
ber glass slides (20 x 104 cells/chamber) in Iscove 
medium. The medium was either supplemented with 
insulin, hydrocortisone, somastatin, human transferrin 
and gly-his-lys three peptide in 0.5% FCS (5H-medium) 
or with 10% FCS. 
Cell cultures 
TECs were allowed to adhere overnight to the glass 
slides. After washing with medium, slides were cultured 
for a further 4 to 5 days with, without, or combinations 
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of the following agents: interferon-y (IFN-y) 10 U/ml, 
bovine thyrotropin (bTSH) 1-100 mU/ml methimazole 
(MMI) 1-100 UM; Perchlorate (PC) 1-100 [XM; sodium 
iodide (Nal) 0.1 mM; IgG 0.1 mg/ml. In some experi-
ments supernatants from TECs were collected after 
2 days and tested on secondary T E C cultures. 
Indirect immunofluorescence (IF) 
After pre-incubation TECs were washed and incubated 
with monoclonal antibodies: Tu 22 — specific for HLA-
DQ; Tu 35 - specific for HLA-DP/DR; Tu 39 -
specific for HLA-DR/DP; DAKO-DRC1 - specific for 
T-cells (equivalent to OKT1); DAKO-DR reacting with 
the ß-chain and DAKO-macrophage (0M). The M-
angigen of thyroid cells was stained with inactivated, 
diluted patient's sera (a-Ml: 3202; negative for a-Tg). 
Rabbit-anti-mouse-IgG (F(ab)2)-FITC and T R I T C con-
jugated rabbit-anti-human IgG were used as second 
antibodies. IF was assessed with an Olympus photo-
fluorescence-microscope B-H2. 
Further procedures 
IgGs were prepared by ion-exchange chromatography. 
IgGs from GD-patients were TSab and a-M positive, 
while IgGs from NTG and normals had no autoanti-
bodies as measured by specific ELISAs. 
Materials 
Collagenase (Dispase II) was from Boehringer, Mann-
heim, FRG. Foetal calf serum (FSC), Iscove medium 
and all cell culture additives were from Biochrom, 
West-Berlin. Monoclonal, Tu-22/35/39 and interleu-
kin-2 were from Biotest, Dreieich, FRG. FITC and 
T R I T C conjugated second antibodies were from Dako-
patt, Hamburg, FRG. Interferon-y, Methimazole and 
all hormone additives were from Sigma Chemie, Mu-
nich, FRG. Sodium iodine and potassium perchlorate 
were from E. Merck, Darmstadt, FRG. Thyrotropin 
(Thyreostimulin) was from Organon, Munich FRG. 
Micro-Lab slides (Miles) and sheep erythrocytes were 
from Flow, Meckenheim, FRG. A BH-2 from Olympus 
Europe, Hamburg, FRG was used. 
Results 
TECs reassociate i n cultures into dome-like struc-
tures sometime resembling micro-follicles as 
shown i n Fig. 1. Under low serum conditions 
(5H-medium) the cellular polarity o f these struc-
tures appears ' r ight side r ight ' . 
I n Fig. 2 this particular morphology is demon-
strated by nucleii surrounding a lumen wi th 
microv i l l i and filaments o f TECs point ing inside. 
T h e ability of various agents to induce class-11 
depends on the source o f the TECs, the agent 
used, and the polarity o f cells i n cultures. IFN-y 
induced H L A - D R , but not M-antigen regardless 
Fig.l. 
Re-association of thyroid epithelial cells under serum-free (5H-medium) culture conditions. 
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o f t h e culture conditions or whether TECs derive 
f r o m GD-patients or patients wi th N T G (Table 1). 
A l l agents acting on the TSH-receptor, i.e. T S H 
and I g G f r o m hyperthyroid GD-patients, induce 
M-antigen (Table 1). H L A - D R together with M -
antigen is only induced in 5H-medium (Fig. 3; 
Table 1). 
A spontaneous expression o f H L A - D R was ob-
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Table 1. 
Expression of HLA-DR and M-antigen by thyroid epi-
thelial cells derived from patients with Graves' disease or 
with non-toxic goitre. 
Graves' disease N on-toxic 
goitre 
5H 5H FCS 
DR M DR M DR M 
IFN-y + + + _ + + + _ + + + _ 
TSH + + + + + - + + + - + + + 
IgG* 4- + + - + + - + + 
IgGNTG - - - - - -IgG** — - — - — -
* Hyperthyroid GD-patients. * * Euthyroid GD-patients. 
Table 2. 
Spontaneous expression of HLA-DR by the thyroid epi-
thelial cells derived from hyperthyroid patients with 
Graves' disease. 
5H 
(lday) 
5H 
(5 days) 
5H 
(5 days + TSH) 
SN* 
HLA-DR 
M-antigen 
+ 
+ + - + + -
* Supernatant from spontaneously HLA-DR expressing 
thyroid epithelial cells applied on secondary NTG-cell 
cultures for 5 days. 
Fig. 3. 
Expression of HLA-DR and M-antigen by thyroid epithelial cells from patients with Graves' disease. Cells were 
incubated with 1 mU/ml bTSH in 5H-medium for 4 days; magnification approx x 450. A: a-M + a-hlgG-TRITC. 
B: ct-HLA-DR + a-mlgG-FITC. 
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Table 3. 
Expression of H L A - D polymorphism, lymphocyte-, macrophage-, and dendritic cell antigens 
by thyroid epithelial cells from Graves' patients. 
D R D P / D R D Q T1/T2 0M DRC1 
IFN-y + + + + + + + + _ _ _ 
T S H + + + - - - -IgG* + + + - - - -5H(iday) + (+) - - - -
Cells grown in 5H-medium. 
served in some TEC-cuitures derived f rom GD-
patients (Table 2). Th i s disappeared after 5 days 
i n culture. But H L A - D R expression could be 
re-induced with T S H . Supernatants (SN) o f these 
part icular TEC-cultures could not induce class-II 
expression, when appl ied on secondary TEC-cul-
tures. W h e n the H L A - D polymorphism o f class-II 
expressing TECs was assessed, different staining 
patterns were observed w i t h different inducing 
agents. While T S H , I g G - G D * induced, and spon-
taneously expressing TECs never displayed H L A -
DQ, a br ight stain o f H L A - D Q was found after 
I F N - y incubation (Table 3). 
TEC-cultures were investigated by means o f IF 
w i t h specific monoclonal antibodies for contamin-
ations w i t h dendrit ic cells, macrophages or T-
cells. Only in cultures w i t h FCS could a weak 
staining o f scattered macrophages sometimes be 
observed. When the effect o f M M I or PC on 
IFN-y o r T S H induced H L A - D expression was 
investigated, only a slight decrease o f H L A - D 
staining could be observed (Table 4 ) . 
Discussion 
A d m i t t e d l y , these i n v i t r o studies can only give 
l i m i t e d information about the induct ion o f class-
I I expression by TECs in vivo. O u r studies sug-
gest, however, that the chronic stimulation o f 
TECs through the TSH-receptor as well as the 
cellular polarity o f TECs play a role in the modu-
lat ion o f class-II expression. We postulate that the 
cellular polarity modulates the availability o f 
TSH-receptors i n TEC-cultures (Mauchamp et al. 
1 9 7 9 ) . This appears to be the reason, why the 
induct ion and reexpression o f class-II antigen by 
T S H could only be observed under serum free 
cul ture conditions. T h e class-II expression o f 
TECs i n vivo (Londei et al. 1 9 8 4 ) resembles more 
generally the staining pattern we observed after 
induct ion w i t h T S H than that w i t h IFN -Y. L N 
contrast to TEC-cultures expressing spontane-
ously H L A - D R and M-antigen, IFN-Y strongly 
induces H L A - D Q , and can induce i n v i t ro TECs 
derived f r o m autoimmune (GD) as well as non-
i m m u n e ( N T G ) thyro id patients. Moreover, we 
could not detect by means o f indirect IF contami-
nat ing dendrit ic cells, T-cells or macrophages 
which would account for IFN -Y product ion in our 
serum free culture system. I n addition to that, the 
supernatants o f spontaneously class-II expressing 
TEC-cultures could not induce class-II in second-
ary TECs, which one would expect i f I F N - Y would 
be produced by contaminating activated lympho-
cytes i n TECs. O n the other hand, we could also 
Table 4. 
Effect of methimazole (MMI) and perchlorate (PC) on the H L A - D R of thyroid epithelial cells. 
I F N - Y + M M I + P C + T S H T S H + M M I + P C 
D R + + + + + + + + + + + + + + + + 
+ + + + + + + + + + - - -
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not detect interleukin-1 i n these supernatants (not 
shown). 
T h e effect M M I has d u r i n g suppression ther-
apy o f G D in vivo and on antibody synthesis in 
v i t r o (McGregor et al. 1980) has been attributed 
to immuno-suppressive effects. I n our hands, 
M M I and PC have no effect on class-II expression 
o f TECs. This reflects previous findings i n re-
c u r r e n t hyperthyroidism o f GD-patients (Carel et 
al. 1986) and findings i n GD-therapy where M M I 
had the same effect as PC, which surely is not 
considered as an immuno-suppressive d r u g (Wen-
zel et al . 1984). 
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